We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session

Applications of ion beam treatment planning
6030
Poster (digital)
Physics
A-priori beam energy selection for heavy ion arc therapy
Lennart Volz, Germany
PO-1494
Protons versus photons for oligometastatic prostate cancer: a planning comparison
Kato Rans, Belgium
PO-1495
Comparing standard proton planning strategy for sinonasal cancer with pseudo-arc multifield approach
Raul Argota Perez, Denmark
PO-1496
Identifying an optimal proton planning strategy for varying bowel density in complex neuroblastomas
Allison Toltz, United Kingdom
PO-1497
Reduction of setup uncertainty in proton therapy for mediastinal lymphoma patients.
Pietro Pisciotta, The Netherlands
PO-1498
Pediatric proton whole lung irradiation
Stella Flampouri, USA
PO-1499
Robustness evaluation of ultra hypo-fractionated IMPT for PCa on target and OAR dose-constraints
Senquan Feng, Netherlands Antilles
PO-1500
Evaluation of proton PBS treatment planning guidelines for brain tumours using a variable RBE model
Anne Vestergaard, Denmark
PO-1501
The clinical benefit of range uncertainty reduction in robust optimization for proton therapy
Ivanka Sojat Tarp, Denmark
PO-1502
MRI-based Synthetic CT images for IMPT Treatment Planning of Nasopharyngeal Carcinoma Patients
Shupeng Chen, USA
PO-1503
Comparison of single and dual-energy CT based proton treatment planning for neuro patients
Tim van der Maas, The Netherlands
PO-1504
Feasibility of acute hematologic toxicity model-based patient selection for proton beam therapy
Peilin Liu, China
PO-1505
Healthy tissue sparing in proton therapy of lung tumors using statistically sound robust planning
Vlad Badiu, Belgium
PO-1506
Dose comparison of clinical robust intensity modulated proton therapy plans for testicular seminoma
Heidi S. Rønde, Denmark
PO-1507
Bone versus soft tissue setup in proton therapy for patients with oesophageal cancer
Muhammad Shamshad, Austria
PO-1508
Proton therapy for nasopharyngeal cancer: dosimetric and NTCP analysis supporting clinical decision
Alessandro Vai, Italy
PO-1509